|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4B
|
|
pubmed:dateCreated |
2006-8-4
|
|
pubmed:abstractText |
The estrogen receptor alpha (ESR1) mediates the effect of estrogen in target tissues. Estrogen is important in breast cancer development and several polymorphic variants in the ESR1 gene have been investigated for association with breast cancer. The C975G variant is the most extensively studied and has been suggested to be a risk factor.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0250-7005
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
26
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
3077-81
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16886637-Adult,
pubmed-meshheading:16886637-Aged,
pubmed-meshheading:16886637-Aged, 80 and over,
pubmed-meshheading:16886637-Breast Neoplasms,
pubmed-meshheading:16886637-Case-Control Studies,
pubmed-meshheading:16886637-Estrogen Receptor alpha,
pubmed-meshheading:16886637-Genes, BRCA1,
pubmed-meshheading:16886637-Genes, BRCA2,
pubmed-meshheading:16886637-Genetic Predisposition to Disease,
pubmed-meshheading:16886637-Genotype,
pubmed-meshheading:16886637-Humans,
pubmed-meshheading:16886637-Middle Aged
|
|
pubmed:articleTitle |
The estrogen receptor alpha C975G variant in familial and sporadic breast cancer: a case-control study.
|
|
pubmed:affiliation |
Department of Molecular Medicine and Surgery, Karolinska Institute, S-171 76 Stockholm, Sweden.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
